▶ 調査レポート

世界のがん検査キット市場 2028年:FIT検査、HPV検査、PSA検査、AFP検査、CEA検査、その他

• 英文タイトル:Global Cancer Testing Kits Market Insights, Forecast to 2028

Global Cancer Testing Kits Market Insights, Forecast to 2028「世界のがん検査キット市場 2028年:FIT検査、HPV検査、PSA検査、AFP検査、CEA検査、その他」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C3647
• 出版社/出版日:QYResearch / 2022年7月11日
• レポート形態:英文、PDF、118ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のがん検査キットの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にがん検査キットの世界市場のxxx%を占める「FIT検査」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「結腸直腸がん」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のがん検査キットの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのがん検査キット市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのがん検査キット市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

がん検査キットのグローバル主要メーカーには、Abbott、AB ANALITICA、Boditech Med、LetsGetChecked、Everlywell、Pinnacle Biolabs、IDL Biotech、Quidel Corporation、Osang Healthcare、Gencurix、Eurolyser Diagnostica、iDNA、GRAIL、imaware、Check4Cancer、Labcorp、Cologuardなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

がん検査キット市場は、種類と用途によって区分されます。世界のがん検査キット市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
FIT検査、HPV検査、PSA検査、AFP検査、CEA検査、その他

【用途別セグメント】
結腸直腸がん、乳がん、肺がん、卵巣がん、前立腺がん、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- がん検査キット製品概要
- 種類別市場(FIT検査、HPV検査、PSA検査、AFP検査、CEA検査、その他)
- 用途別市場(結腸直腸がん、乳がん、肺がん、卵巣がん、前立腺がん、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のがん検査キット販売量予測2017-2028
- 世界のがん検査キット売上予測2017-2028
- がん検査キットの地域別販売量
- がん検査キットの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別がん検査キット販売量
- 主要メーカー別がん検査キット売上
- 主要メーカー別がん検査キット価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(FIT検査、HPV検査、PSA検査、AFP検査、CEA検査、その他)
- がん検査キットの種類別販売量
- がん検査キットの種類別売上
- がん検査キットの種類別価格
・用途別市場規模(結腸直腸がん、乳がん、肺がん、卵巣がん、前立腺がん、その他)
- がん検査キットの用途別販売量
- がん検査キットの用途別売上
- がん検査キットの用途別価格
・北米市場
- 北米のがん検査キット市場規模(種類別、用途別)
- 主要国別のがん検査キット市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのがん検査キット市場規模(種類別、用途別)
- 主要国別のがん検査キット市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のがん検査キット市場規模(種類別、用途別)
- 主要国別のがん検査キット市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のがん検査キット市場規模(種類別、用途別)
- 主要国別のがん検査キット市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのがん検査キット市場規模(種類別、用途別)
- 主要国別のがん検査キット市場規模(トルコ、サウジアラビア)
・企業情報
Abbott、AB ANALITICA、Boditech Med、LetsGetChecked、Everlywell、Pinnacle Biolabs、IDL Biotech、Quidel Corporation、Osang Healthcare、Gencurix、Eurolyser Diagnostica、iDNA、GRAIL、imaware、Check4Cancer、Labcorp、Cologuard
・産業チェーン及び販売チャネル分析
- がん検査キットの産業チェーン分析
- がん検査キットの原材料
- がん検査キットの生産プロセス
- がん検査キットの販売及びマーケティング
- がん検査キットの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- がん検査キットの産業動向
- がん検査キットのマーケットドライバー
- がん検査キットの課題
- がん検査キットの阻害要因
・主な調査結果

Cancer is the leading cause of death. Cancer symptoms can be subtle, and many go undetected until the cancer is in an advanced stage.However, a person can take steps to help prevent cancer and catch it early. Screenings and early detection can increase a person’s chance of receiving successful treatment and making a recovery.

Cancer test kits help detect and screen for cancers in their early, more treatable stage, sometimes before a person shows any symptoms.
Market Analysis and Insights: Global Cancer Testing Kits Market
Due to the COVID-19 pandemic, the global Cancer Testing Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, FIT Test accounting for % of the Cancer Testing Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Colorectal Cancer segment is altered to an % CAGR throughout this forecast period.
China Cancer Testing Kits market size is valued at US$ million in 2021, while the US and Europe Cancer Testing Kits are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cancer Testing Kits landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Cancer Testing Kits include Abbott, AB ANALITICA, Boditech Med, LetsGetChecked, Everlywell, Pinnacle Biolabs, IDL Biotech, Quidel Corporation and Osang Healthcare, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Cancer Testing Kits Scope and Segment
Cancer Testing Kits market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cancer Testing Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
FIT Test
HPV Test
PSA Test
AFP Test
CEA Test
Others
Segment by Application
Colorectal Cancer
Breast Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Others
By Company
Abbott
AB ANALITICA
Boditech Med
LetsGetChecked
Everlywell
Pinnacle Biolabs
IDL Biotech
Quidel Corporation
Osang Healthcare
Gencurix
Eurolyser Diagnostica
iDNA
GRAIL
imaware
Check4Cancer
Labcorp
Cologuard
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Cancer Testing Kits Product Introduction
1.2 Market by Type
1.2.1 Global Cancer Testing Kits Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 FIT Test
1.2.3 HPV Test
1.2.4 PSA Test
1.2.5 AFP Test
1.2.6 CEA Test
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cancer Testing Kits Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Colorectal Cancer
1.3.3 Breast Cancer
1.3.4 Lung Cancer
1.3.5 Ovarian Cancer
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cancer Testing Kits Sales Estimates and Forecasts 2017-2028
2.2 Global Cancer Testing Kits Revenue Estimates and Forecasts 2017-2028
2.3 Global Cancer Testing Kits Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cancer Testing Kits Sales by Region
2.4.1 Global Cancer Testing Kits Sales by Region (2017-2022)
2.4.2 Global Sales Cancer Testing Kits by Region (2023-2028)
2.5 Global Cancer Testing Kits Revenue by Region
2.5.1 Global Cancer Testing Kits Revenue by Region (2017-2022)
2.5.2 Global Cancer Testing Kits Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cancer Testing Kits Sales by Manufacturers
3.1.1 Global Top Cancer Testing Kits Manufacturers by Sales (2017-2022)
3.1.2 Global Cancer Testing Kits Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cancer Testing Kits in 2021
3.2 Global Cancer Testing Kits Revenue by Manufacturers
3.2.1 Global Cancer Testing Kits Revenue by Manufacturers (2017-2022)
3.2.2 Global Cancer Testing Kits Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cancer Testing Kits Revenue in 2021
3.3 Global Cancer Testing Kits Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cancer Testing Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cancer Testing Kits Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cancer Testing Kits Sales by Type
4.1.1 Global Cancer Testing Kits Historical Sales by Type (2017-2022)
4.1.2 Global Cancer Testing Kits Forecasted Sales by Type (2023-2028)
4.1.3 Global Cancer Testing Kits Sales Market Share by Type (2017-2028)
4.2 Global Cancer Testing Kits Revenue by Type
4.2.1 Global Cancer Testing Kits Historical Revenue by Type (2017-2022)
4.2.2 Global Cancer Testing Kits Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cancer Testing Kits Revenue Market Share by Type (2017-2028)
4.3 Global Cancer Testing Kits Price by Type
4.3.1 Global Cancer Testing Kits Price by Type (2017-2022)
4.3.2 Global Cancer Testing Kits Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cancer Testing Kits Sales by Application
5.1.1 Global Cancer Testing Kits Historical Sales by Application (2017-2022)
5.1.2 Global Cancer Testing Kits Forecasted Sales by Application (2023-2028)
5.1.3 Global Cancer Testing Kits Sales Market Share by Application (2017-2028)
5.2 Global Cancer Testing Kits Revenue by Application
5.2.1 Global Cancer Testing Kits Historical Revenue by Application (2017-2022)
5.2.2 Global Cancer Testing Kits Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cancer Testing Kits Revenue Market Share by Application (2017-2028)
5.3 Global Cancer Testing Kits Price by Application
5.3.1 Global Cancer Testing Kits Price by Application (2017-2022)
5.3.2 Global Cancer Testing Kits Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cancer Testing Kits Market Size by Type
6.1.1 North America Cancer Testing Kits Sales by Type (2017-2028)
6.1.2 North America Cancer Testing Kits Revenue by Type (2017-2028)
6.2 North America Cancer Testing Kits Market Size by Application
6.2.1 North America Cancer Testing Kits Sales by Application (2017-2028)
6.2.2 North America Cancer Testing Kits Revenue by Application (2017-2028)
6.3 North America Cancer Testing Kits Market Size by Country
6.3.1 North America Cancer Testing Kits Sales by Country (2017-2028)
6.3.2 North America Cancer Testing Kits Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Cancer Testing Kits Market Size by Type
7.1.1 Europe Cancer Testing Kits Sales by Type (2017-2028)
7.1.2 Europe Cancer Testing Kits Revenue by Type (2017-2028)
7.2 Europe Cancer Testing Kits Market Size by Application
7.2.1 Europe Cancer Testing Kits Sales by Application (2017-2028)
7.2.2 Europe Cancer Testing Kits Revenue by Application (2017-2028)
7.3 Europe Cancer Testing Kits Market Size by Country
7.3.1 Europe Cancer Testing Kits Sales by Country (2017-2028)
7.3.2 Europe Cancer Testing Kits Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cancer Testing Kits Market Size by Type
8.1.1 Asia Pacific Cancer Testing Kits Sales by Type (2017-2028)
8.1.2 Asia Pacific Cancer Testing Kits Revenue by Type (2017-2028)
8.2 Asia Pacific Cancer Testing Kits Market Size by Application
8.2.1 Asia Pacific Cancer Testing Kits Sales by Application (2017-2028)
8.2.2 Asia Pacific Cancer Testing Kits Revenue by Application (2017-2028)
8.3 Asia Pacific Cancer Testing Kits Market Size by Region
8.3.1 Asia Pacific Cancer Testing Kits Sales by Region (2017-2028)
8.3.2 Asia Pacific Cancer Testing Kits Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Cancer Testing Kits Market Size by Type
9.1.1 Latin America Cancer Testing Kits Sales by Type (2017-2028)
9.1.2 Latin America Cancer Testing Kits Revenue by Type (2017-2028)
9.2 Latin America Cancer Testing Kits Market Size by Application
9.2.1 Latin America Cancer Testing Kits Sales by Application (2017-2028)
9.2.2 Latin America Cancer Testing Kits Revenue by Application (2017-2028)
9.3 Latin America Cancer Testing Kits Market Size by Country
9.3.1 Latin America Cancer Testing Kits Sales by Country (2017-2028)
9.3.2 Latin America Cancer Testing Kits Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Cancer Testing Kits Market Size by Type
10.1.1 Middle East and Africa Cancer Testing Kits Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cancer Testing Kits Revenue by Type (2017-2028)
10.2 Middle East and Africa Cancer Testing Kits Market Size by Application
10.2.1 Middle East and Africa Cancer Testing Kits Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cancer Testing Kits Revenue by Application (2017-2028)
10.3 Middle East and Africa Cancer Testing Kits Market Size by Country
10.3.1 Middle East and Africa Cancer Testing Kits Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cancer Testing Kits Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 AB ANALITICA
11.2.1 AB ANALITICA Corporation Information
11.2.2 AB ANALITICA Overview
11.2.3 AB ANALITICA Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AB ANALITICA Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AB ANALITICA Recent Developments
11.3 Boditech Med
11.3.1 Boditech Med Corporation Information
11.3.2 Boditech Med Overview
11.3.3 Boditech Med Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boditech Med Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boditech Med Recent Developments
11.4 LetsGetChecked
11.4.1 LetsGetChecked Corporation Information
11.4.2 LetsGetChecked Overview
11.4.3 LetsGetChecked Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 LetsGetChecked Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LetsGetChecked Recent Developments
11.5 Everlywell
11.5.1 Everlywell Corporation Information
11.5.2 Everlywell Overview
11.5.3 Everlywell Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Everlywell Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Everlywell Recent Developments
11.6 Pinnacle Biolabs
11.6.1 Pinnacle Biolabs Corporation Information
11.6.2 Pinnacle Biolabs Overview
11.6.3 Pinnacle Biolabs Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pinnacle Biolabs Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pinnacle Biolabs Recent Developments
11.7 IDL Biotech
11.7.1 IDL Biotech Corporation Information
11.7.2 IDL Biotech Overview
11.7.3 IDL Biotech Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 IDL Biotech Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 IDL Biotech Recent Developments
11.8 Quidel Corporation
11.8.1 Quidel Corporation Corporation Information
11.8.2 Quidel Corporation Overview
11.8.3 Quidel Corporation Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Quidel Corporation Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Quidel Corporation Recent Developments
11.9 Osang Healthcare
11.9.1 Osang Healthcare Corporation Information
11.9.2 Osang Healthcare Overview
11.9.3 Osang Healthcare Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Osang Healthcare Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Osang Healthcare Recent Developments
11.10 Gencurix
11.10.1 Gencurix Corporation Information
11.10.2 Gencurix Overview
11.10.3 Gencurix Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Gencurix Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Gencurix Recent Developments
11.11 Eurolyser Diagnostica
11.11.1 Eurolyser Diagnostica Corporation Information
11.11.2 Eurolyser Diagnostica Overview
11.11.3 Eurolyser Diagnostica Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Eurolyser Diagnostica Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Eurolyser Diagnostica Recent Developments
11.12 iDNA
11.12.1 iDNA Corporation Information
11.12.2 iDNA Overview
11.12.3 iDNA Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 iDNA Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 iDNA Recent Developments
11.13 GRAIL
11.13.1 GRAIL Corporation Information
11.13.2 GRAIL Overview
11.13.3 GRAIL Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 GRAIL Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 GRAIL Recent Developments
11.14 imaware
11.14.1 imaware Corporation Information
11.14.2 imaware Overview
11.14.3 imaware Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 imaware Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 imaware Recent Developments
11.15 Check4Cancer
11.15.1 Check4Cancer Corporation Information
11.15.2 Check4Cancer Overview
11.15.3 Check4Cancer Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Check4Cancer Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Check4Cancer Recent Developments
11.16 Labcorp
11.16.1 Labcorp Corporation Information
11.16.2 Labcorp Overview
11.16.3 Labcorp Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Labcorp Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Labcorp Recent Developments
11.17 Cologuard
11.17.1 Cologuard Corporation Information
11.17.2 Cologuard Overview
11.17.3 Cologuard Cancer Testing Kits Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Cologuard Cancer Testing Kits Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Cologuard Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cancer Testing Kits Industry Chain Analysis
12.2 Cancer Testing Kits Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cancer Testing Kits Production Mode & Process
12.4 Cancer Testing Kits Sales and Marketing
12.4.1 Cancer Testing Kits Sales Channels
12.4.2 Cancer Testing Kits Distributors
12.5 Cancer Testing Kits Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cancer Testing Kits Industry Trends
13.2 Cancer Testing Kits Market Drivers
13.3 Cancer Testing Kits Market Challenges
13.4 Cancer Testing Kits Market Restraints
14 Key Findings in The Global Cancer Testing Kits Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer